Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: A study of 154 cases

American Journal of Hematology

Volumn 88, Issue 2, 2013, Pages 93-96

  Kamesaki, Toyomi ^a   Toyotsuji, Tomonori ^a   Kajii, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN; RITUXIMAB; STEROID;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; COOMBS TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIRECT ANTIGLOBULIN TEST NEGATIVE AUTOIMMUNE HEMOLYTIC ANEMIA; DIRECT ANTIGLOBULIN TEST POSITIVE AUTOIMMUNE HEMOLYTIC ANEMIA; DRUG EFFICACY; ERYTHROCYTE; FEMALE; FOLLOW UP; HAZARD RATIO; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNORADIOMETRIC ASSAY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PLASMAPHERESIS; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; SCHOOL CHILD; SPLENECTOMY; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BLOOD PROTEINS; CASE-CONTROL STUDIES; COOMBS TEST; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN G; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; RETICULOCYTE COUNT; SEVERITY OF ILLNESS INDEX; STEROIDS; SURVIVAL ANALYSIS;

EID: 84872945354     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23356     Document Type: Article

References (26)

1. Petz LD, Garratty G. Warm antibody autoimmune hemolytic anemia. Corticosteroid therapy. Petz LD, Garratty G, editors. Immune Hemolytic Anemias. Philadelphia:Churchill Livingstone;2004. pp401-407.
2. Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol 1976;13:323-334.
3. Dameshek W, Komninos ZD. The present status of treatment of autoimmune hemolytic anemia with ACTH and cortisone. Blood 1956;11:648-664.
4. Allgood JW, Chaplin HJr. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med 1967;43:254-273.
5. Zupanska B, Sylwestrowicz T, Pawelski S. The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia (Budap) 1981;14:425-433.
6. Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol 1992;29:3-12.
7. Roback JD, Barclay S, Hillyer CD. An automatable format for accurate immunohematology testing by flow cytometry. Transfusion 2003;43:918-927.
8. Stroncek DF, Njoroge JM, Procter JL, et al. A preliminary comparison of flow cytometry and tube agglutination assays in detecting red blood cell-associated C3d. Transfus Med 2003;13:35-41.
9. Gilliland BC. Coombs-negative immune hemolytic anemia. Semin Hematol 1976;13:267-275.
10. Evans RS, Weiser RS. The serology of autoimmune hemolytic disease; observations on forty-one patients. AMA Arch Intern Med 1957;100:371-399.
11. Worlledge SM, Blajchman MA. The autoimmune haemolytic anaemias. Br J Haematol 1972;23:61-69.
12. Chaplin HJr. Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias. Prog Hematol 1973;8:25-49.
13. Issitt DP, Gutgseu NS. Clinically significant antibodies not detected by routine methods. Nance S, editor. Immune Destruction of Red Blood Cells. Arlington:American Association of Blood Banks;1989. pp93-99.
14. Petz LD, Garratty G. Unusual aspects of acquired immune hemolytic anemias. A autoimmune hemolytic anemia with a negative direct antiglobulin test (DAT). Petz LD, Garratty G, editors. Immune Hemolytic Anemias. Philadelphia:Churchill Livingstone;2004. pp319-334.
15. Jeje MO, Blajchman MA, Steeves K, et al. Quantitation of red cell-associated IgG using an immunoradiometric assay. Transfusion 1984;24:473-476.
16. Kamesaki T, Oyamada T, Omine M, et al. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Am J Hematol 2009;84:98-101.
17. Engelfriet CP, von dem Borne AEG, Beckers D, et al. Immune destruction of red cells. Bell CA, editor.A Seminar on Immune-Mediated Cell Destruction. Washington, DC:American Association of Blood Banks;1981. pp93-130.
18. Zupanska B, Brojer E, Maslanka K, Hallberg T. A comparison between Fc receptors for IgG1 and IgG3 on human monocytes and lymphocytes using anti-Rh antibodies. Vox Sang 1985;49:67-76.
19. Petz LD, Garratty G, editors. Acquired Immune Hemolytic Anemias, 1st ed. New York:Churchill Livingstone;1980.
20. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood 2010;116:1831-1838.
21. Toyotsuji T, Kamesaki T, Kajii E. Coombs-positive and negative autoimmune hemolytic anemia might immunologically differ. Rinsho Ketsueki (Japanese J Clin Hematol) 2011;52:461.
22. Petz LD, Garratty G. Prognosis and survival. Warm antibody AIHA. Petz LD, Garratty G, editors. Immune Hemolytic Anemias. Philadelphia:Churchill Livingstone;2004. pp70-71.
23. Dausset J, Colombani J. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. Blood 1959;14:1280-1301.
24. Crosby WH, Rappaport H. Autoimmune hemolytic anemia. I. Analysis of hematologic observations with particular reference to their prognostic value; a survey of 57 cases. Blood 1957;12:42-55.
25. Crosby WH. The clinical aspects of immunologic hemolytic anemia. Vox Sang 1955;26:3-6.
26. Nakasone H, Kako S, Endo H, et al. Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia. Hematology 2009;14:361-365.